Priothera
Recent Finacing
Equity
Recent Raise
$3.5M
Priothera is a Franco-Irish biotech developing mocravimod, an oral immunomodulator intended to become a standard therapy for blood cancers.
Recent Finacing
Recent Raise
Priothera is a Franco-Irish biotech developing mocravimod, an oral immunomodulator intended to become a standard therapy for blood cancers.
